3,5-Dicaffeoyl-4-malonylquinic acid reduced oxidative stress and inflammation in a experimental model of inflammatory bowel disease

Free Radical Research

Volumn 44, Issue 1, 2010, Pages 74-89

  Di Paola, Rosanna ^a   Esposito, Emanuela ^a,b   Mazzon, Emanuela ^a   Caminiti, Rocco ^c   Toso, Roberto Dal ^d   Pressi, Giovanna ^d   Cozzocrea, Salvatore ^a,c  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d IRB Srl   (Italy)

Author keywords

3,5 Dicaffeoyl 4 malonylquinic acid; B; Colitis; Neutrophil infi ltration; NF

Indexed keywords

3 NITROTYROSINE; 3,5 DICAFFEOYL 4 MALONYLQUINIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BENZENESULFONIC ACID DERIVATIVE; CENTELLA ASIATICA EXTRACT; CYTOKINE; DINITROBENZENESULFONIC ACID; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CENTELLA ASIATICA; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE RELEASE; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENTERITIS; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAFFEIC ACIDS; CELLS, CULTURED; CENTELLA; CHLOROGENIC ACID; COLON; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MALE; MODELS, BIOLOGICAL; OXIDATIVE STRESS; QUINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TRITERPENES;

CENTELLA ASIATICA; RATTUS;

EID: 71649104469     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715760903300709     Document Type: Article

References (76)

1. Hung TM, Na M, Thuong PT, Su ND, Sok D, Song KS, Seong YH, Bae K. Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J Ethnop-harmacol 2006;108:188-192.
2. Iwai K, Kishimoto N, Kakino Y, Mochida K, Fujita T. In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. J Agric food Chem 2004;52:4893-4898.
3. Gongora L, Manez S, Giner RM, Recio Mdel C, Schinella G, Rios JL. Inhibition of xanthine oxidase by phenolic conjugates of methylated quinic acid. Planta Med 2003;69:396-401.
4. Nakatani N, Kayano S, Kikuzaki H, Sumino K, Katagiri K, Mitani T. Identifi cation, quantitative determination, and antioxidative activities of chlorogenic acid isomers in prune (Prunus domestica L.). J Agric Food Chem 2000;48: 5512-5516.
5. Mishima S, Inoh Y, Narita Y, Ohta S, Sakamoto T, Araki Y, Suzuki KM, Akao Y, NozawaY. Identifi cation of caffeoylquinic acid derivatives from Brazilian propolis as constituents involved in induction of granulocytic differentiation of HL-60 cells. Bioorg Med Chem 2005;13:5814-5818.
6. Xiang T, Xiong QB, Ketut AI, Tezuka Y, Nagaoka T, Wu LJ, Kadota S. Studies on the hepatocyte protective activity and the structure-activity relationships of quinic acid and caffeic acid derivatives from the fl ower buds of Lonicera bournei. Planta Med 2001;67:322-325.
7. Basnet P, Matsushige K, Hase K, Kadota S, Namba T. Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 1996;19:1479-1484.
8. Gongora L, Giner RM, Manez S, Recio Mdel C, Schinella G, Rios JL. Effects of caffeoyl conjugates of isoprenyl-hydroquinone glucoside and quinic acid on leukocyte function. Life Sci 2002;71:2995-3004.
9. Zhu X, Zhang H, Lo R. Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J Agric Food Chem 2004;52:7272-7278.
10. Yoshimoto M, Yahara S, Okuno S, Islam MS, Ishiguro K, Yamakawa O. Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweetpotato (Ipomoea batatas L.) leaf. Biosci Biotechnol Biochem 2002;66:2336-2341.
11. Tang D, Li HJ, Li P, Wen XD, Qian ZM. Interaction of bioac-tive components caffeoylquinic acid derivatives in Chinese medicines with bovine serum albumin. Chem Pharm Bull 2008;56:360-365.
12. Yonathan M, Asres K, Assefa A, Bucar F. In vivo anti-infl ammatory and anti-nociceptive activities of Cheilanthes farinosa. J Ethnopharmacol 2006;108:462-470.
13. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. Health benefi ts of herbs and spices: the past, the present, the future. Med J Aust 2006;185:S4-S24.
14. Ivanov V, Ivanova S, Kalinovsky T, Niedzwiecki A, Rath M. Plant-derived micronutrients suppress monocyte adhesion to cultured human aortic endothelial cell layer by modulating its extracellular matrix composition. J Cardiovasc Pharmacol 2008;52:55-65.
15. Belcaro GV, Grimaldi R, Guidi G. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA. Angiology 1990;41:533-540. (Pubitemid 20263007)
16. Belcaro GV, Rulo A, Grimaldi R. Capillary fi ltration and ankle edema in patients with venous hypertension treated with TTFCA. Angiology 1990;41:12-18. (Pubitemid 20067112)
17. Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Grimaldi R, Marelli C, Belcaro G. [The microcirculatory activity of Centella asiatica in venous insuffi ciency. A double-blind study]. Minerva Cardioangiologica 1994;42: 299-304.
18. Martinez MJ, Bonfi ll X, Moreno RM, Vargas E, Capella D. Phlebotonics for venous insuffi ciency. Cochrane database of systematic reviews (Online) 2005:CD003229.
19. Inamdar NM, Ahn YI, Alam J. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem Biophys Res Comm 1996;221:570-576. (Pubitemid 26153905)
20. Shukla A, Rasik AM, Jain GK, Shankar R, Kulshrestha DK, Dhawan BN. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999;65:1-11.
21. Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, Manyam BV. Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model. Phytother Res 2009;23:14-19.
22. Papajewski S, Vogler B, Conrad J, Klaiber I, Roos G, Walter CU, Süssmuth R, Kraus W. Isolation from Cussonia barteri of 1'-O-chlorogenoylchlorogenic acid and 1'-O-chlorogenoyl-neochlorogenic acid, a new type of quinic acid esters. Planta Med 2001;67:732-736.
23. Heilmann J, Merfort I, Weiss M. Radical scavenger activity of different 3',4'-dihydroxyfl avonols and 1,5-dicaffeoylquinic acid studied by inhibition of chemiluminescence. Planta Med 1995;61:435-438.
24. Satake T, Kamiya K, An Y, Oishi Nee Taka T, Yamamoto J. The anti-thrombotic active constituents from Centella asiat-ica. Biol Pharm Bull 2007;30:935-940.
25. Baumgart DC, Carding SR. Infl ammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-1640.
26. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411: 603-606.
27. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-1928.
28. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffi ths AM, St George-Hyslop PH, Siminovitch KA. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nature Genet 2004;36:471-475.
29. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, Nikolaus S, Hampe J, Lengauer T, Pierrou S, Foelsch UR, Mathew CG, Lagerstrom-Fermer M, Schreiber S. Genetic variation in DLG5 is associated with infl ammatory bowel disease. Nature Genet 2004;36:476-480.
30. Sartor RB. Review article: role of the enteric microfl ora in the pathogenesis of intestinal infl ammation and arthritis. Alimentary Pharmacol Ther 1997;11(Suppl 3):17-22; discussion 23.
31. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterol-ogy 1998;115:1405-1413.
32. Ibbotson JP, Lowes JR, Chahal H, Gaston JS, Life P, Kumararatne DS, Sharif H, Alexander-Williams J, Allan RN. Mucosal cell-mediated immunity to mycobacterial, enter-obacterial and other microbial antigens in infl ammatory bowel disease. Clin Exp Immunol 1992;87:224-230.
33. Riccardi L, Mazzon E, Bruscoli S, Esposito E, Crisafulli C, Di Paola R, Caminiti R, Riccardi C, Cuzzocrea S. Peroxi-some proliferator-activated receptor-alpha modulates the anti-infl ammatory effect of glucocorticoids in a model of infl ammatory bowel disease in mice. Shock (Augusta, Ga) 2009;31:308-316.
34. Wallace JL, Le T, Carter L, Appleyard CB, Beck PL. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J Pharm Toxicol Methods 1995;33:237-239.
35. Albert CJ, Ford DA. Identifi cation of specifi c nuclear protein kinase C isozymes and accelerated protein kinase C-dependent nuclear protein phosphorylation during myocardial ischemia. FEBS Lett 1998;438:32-36.
36. Heussen C, Dowdle EB. Electrophoretic analysis of plasmino-gen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
37. Grisham MB. Oxidants and free radicals in infl ammatory bowel disease. Lancet 1994;344:859-861.
38. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Digestive Dis Sci 1988;33:6S-15S.
39. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993;341: 465-466.
40. Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, Xavier RJ, Podolsky DK. Peroxynitrite-induced rat colitis-a new model of colonic infl ammation. Gastroenterology 1993;105:1681-1688.
41. Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M. Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Digestive Dis Sci 1988;33:951-955.
42. Kruidenier L, Kuiper I, Lamers CB, Verspaget H W. Intestinal oxidative damage in infl ammatory bowel disease: semi-quantifi cation, localization, and association with mucosal anti-oxidants. J Pathol 2003;201:28-36.
43. Mahida YR, Wu KC, Jewell D P. Respiratory burst activity of intestinal macrophages in normal and infl ammatory bowel disease. Gut 1989;30:1362-1370.
44. Verspaget H, Beeken W. Mononuclear phagocytes in the gastrointestinal tract. Acta Chir Scand 1985;525:113-126.
45. Crama-Bohbouth GE, Arndt JW, Pena AS, Verspaget HW, Tjon ATRT, Weterman IT, Pauwels EK, Lamers CB. Value of indium-111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation. Digestion 1988;40:227-236.
46. Verspaget HW, Pena AS, Weterman IT, Lamers CB. Diminished neutrophil function in Crohn's disease and ulcerative colitis identifi ed by decreased oxidative metabolism and low superoxide dismutase content. Gut 1988;29: 223-228.
47. Cuzzocrea S, Zingarelli B, Hake P, Salzman AL, Szabo C. Antiinfl ammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of infl ammation. Free Radic Biol Med 1998;24:450-459.
48. Ikeda I, Kasajima T, Ishiyama S, Shimojo T, Takeo Y, Nishikawa T, Kameoka S, Hiroe M, Mitsunaga A. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 1997;92:1339-1341.
49. Aiko S, Grisham MB. Spontaneous intestinal infl ammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 1995;109:142-150.
50. Mourelle M, Vilaseca J, Guarner F, Salas A, Malagelada JR. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol 1996;270:G425-G430.
51. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431-437.
52. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996;9:836-844.
53. Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A. TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995;269:L551-L559.
54. Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 1995;371:86-88.
55. Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in infl ammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998;19:287-298.
56. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998;273:14085-14089.
57. Clifford MN, Wu W, Kirkpatrick J, Kuhnert N. Profi ling the chlorogenic acids and other caffeic acid derivatives of herbal chrysanthemum by LC-MSn. J Agric Food Chem 2007;55:929-936.
58. Kono Y, Kobayashi K, Tagawa S, Adachi K, Ueda A, Sawa Y, Shibata H. Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim Biophys Acta 1997;1335:335-342.
59. Shibata H, Sakamoto Y, Oka M, Kono Y. Natural anti-oxidant, chlorogenic acid, protects against DNA breakage caused by monochloramine. Biosci Biotechnol Biochem 1999;63:1295-1297.
60. Castelluccio C, Paganga G, Melikian N, Bolwell GP, Pridham J, Sampson J, Rice-Evans C. Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS Lett 1995;368:188-192.
61. Laranjinha J, Vierira O, Almeida L, Madeira V. Inhibition of metmyoglobin/H2O2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem Pharmacol 1996;51:395-402.
62. Yamanaka N, Oda O, Nagao S. Prooxidant activity of caffeic acid, dietary non-fl avonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. FEBS Lett 1997;405: 186-190.
63. Atreya I, Atreya R, Neurath MF. NF-kappaB in infl ammatory bowel disease. J Intern Med 2008;263:591-596.
64. Yun KJ, Kim JY, Kim JB, Lee KW, Jeong SY, Park HJ, Jung HJ, Cho YW, Yun K, Lee K T. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int Immunopharmacol 2008;8:431-441.
65. Garg P, Vijay-Kumar M, Wang L, Gewirtz AT, Merlin D, Sitaraman SV. Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metallo proteinase-2 during colitis. Am J Physiol 2009;296:G175-G184.
66. Moon SK, Cha BY, Kim CH. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J Cell Physiol 2004;198:417-427.
67. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-kappaB reduces matrix metalloprotein-ase-1,-3 and-9 production by vascular smooth muscle cells. Cardiovasc Res 2001;50:556-565.
68. Felx M, Guyot MC, Isler M, Turcotte RE, Doyon J, Khatib AM, Leclerc S, Moreau A, Moldovan F. Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond) 2006;110:645-654.
69. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinfl ammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585-594.
70. Kapsoritakis AN, Koukourakis MI, Sfi ridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA. Mean platelet volume: a useful marker of infl ammatory bowel disease activity. Am J Gastroenterol 2001;96:776-781.
71. Kawachi S, Jennings S, Panes J, Cockrell A, Laroux FS, Gray L, Perry M, van der Heyde H, Balish E, Granger DN, Specian RA, Grisham MB. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-defi cient mice. Am J Physiol 2000;278:G734-G743.
72. Carter L, Wallace JL. Alterations in rat peripheral blood neu-trophil function as a consequence of colitis. Digestive Dis Sci 1995;40:192-197.
73. Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxida-tive stress in ulcerative colitis. J Clin Biochem Nutrit 2007; 41:18-26.
74. Guo JS, Cheng CL, Koo M W. Inhibitory effects of Centella asiatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in rats. Planta Med 2004;70:1150-1154.
75. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived infl ammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-397.
76. Cuzzocrea S, Thiemermann C, Salvemini D. Potential therapeutic effect of antioxidant therapy in shock and infl ammation. Curr Med Chem 2004;11:1147-1162.